Evaluation of Sofosbuvir (β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine) as an inhibitor of Dengue virus replication<sup/>.

MLA

Xu, Hong-Tao, et al. “Evaluation of Sofosbuvir (β-D-2’-Deoxy-2’-α-Fluoro-2’-β-C-Methyluridine) as an Inhibitor of Dengue Virus Replication^{.” Scientific Reports, vol. 7, no. 1, July 2017, p. 6345. EBSCOhost, https://doi.org/10.1038/s41598-017-06612-2.}

APA

Xu, H.-T., Colby-Germinario, S. P., Hassounah, S. A., Fogarty, C., Osman, N., Palanisamy, N., Han, Y., Oliveira, M., Quan, Y., & Wainberg, M. A. (2017). Evaluation of Sofosbuvir (β-D-2’-deoxy-2’-α-fluoro-2’-β-C-methyluridine) as an inhibitor of Dengue virus replication^{. Scientific Reports, 7(1), 6345. https://doi.org/10.1038/s41598-017-06612-2}

Chicago

Xu, Hong-Tao, Susan P Colby-Germinario, Said A Hassounah, Clare Fogarty, Nathan Osman, Navaneethan Palanisamy, Yingshan Han, Maureen Oliveira, Yudong Quan, and Mark A Wainberg. 2017. “Evaluation of Sofosbuvir (β-D-2’-Deoxy-2’-α-Fluoro-2’-β-C-Methyluridine) as an Inhibitor of Dengue Virus Replication^{.” Scientific Reports 7 (1): 6345. doi:10.1038/s41598-017-06612-2.}